A once-daily oral weight loss medication is coming to the UK. Join the waitlist and we’ll contact you the moment it’s available.
No spam. One update when it launches
A new once-daily oral weight loss pill received FDA approval in the US in December 2025, making it the first pill of its kind approved specifically for weight management in adults. UK approval requires a separate MHRA process, and we expect it soon. No official date has been confirmed.
Once approved, you’ll be able to get it through a licensed UK prescriber. Join the waitlist and we’ll contact you as soon as it’s available through Click2Pharmacy.
Want to start your weight loss journey now?
While you wait for the tablet, we offer a range of licensed weight management treatments available with a private prescription today. Complete a free online consultation and our pharmacists will recommend the most suitable option for you.
The OASIS 4 trial enrolled adults with a BMI of 30 or above (or 27+ with a weight-related condition) over 64 weeks. Patients taking the oral weight loss pill lost an average of 13.6% of their body weight, compared to 2.2% in the placebo group.
The oral weight loss tablet contains the same active ingredient as the weight loss injection. It also contains an absorption enhancer that protects the medication in your stomach and helps it enter your system.
The medication reduces your appetite and helps you feel fuller for longer, so your overall calorie intake goes down. Combining the tablet with a reduced-calorie diet and healthy lifestyle choices like increased activity supports long-term weight loss.
The ~1.4% difference in average weight loss between the two forms is considered unlikely to be clinically significant for most patients. Your prescriber can help decide which is more appropriate for you.
There’s no confirmed launch date, but UK approval is expected soon. The tablet was approved by the FDA in December 2025 and became available in US pharmacies in early 2026. In the UK, new medicines and treatments need approval from the MHRA. Join the waitlist and we’ll let you know the moment it’s approved.
Treatment starts at 1.5 mg once daily and escalates every 30 days – to 4 mg, then 9 mg – before reaching the maintenance dose of 25 mg once daily from day 91. The gradual increase is designed to help your body adapt to the medication and lose weight in a healthy/sustainable way.
Switching is possible under prescriber guidance. Patients stabilised on the injection may be able to move directly to the tablet, with no need to re-escalate, starting one week after their last dose. Speak to your prescriber before making any change.
Join the waitlist and we’ll reach out as soon as the oral weight loss tablet is available through Click2Pharmacy.
